Pharmaceutical companies

These pages contain information on  

  • the quarterly notifications for generic substitution and the reference price system
  • the notification of prices to the Pharmaceutical Database

Notice: Important information on substitutable medicines and the price notification procedure (11 August 2021)

Pharmaceutical companies must report the prices for products that are included in generic substitution and in the reference price system to Kela 4 times a year. The quick guide gives a clear overview of the price notification procedure.